Unlocking Epigenetic Secrets from the Womb: Therapeutic Options for Advanced and Recurrent Endometrial Cancer Evaluation (ID: i778-6) Survey

Question Title

* 2. What is your specialty?

Gynecologic Oncology

Oncology (other focus)

OB/GYN

Emergency Medicine

Internal Medicine

Family Practice

Question Title

* 3. Please select the option that best describes your practice:

Academic medical center

Community medical center

Other (please specify)

Question Title

* 4. How many years have you been in practice?

1-10

11-20

>20

Not in practice

Question Title

* 5. How many patients with EC do you treat each week?

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 6. After participating in this activity, how confident are you in the management of patients with EC in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 7. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Better understanding of biomarkers for EC and their implications for treatment

Improved ability to counsel patients on available treatment options

Increased ability to select treatment based on individual patient profiles

Improved understanding of how to monitor for and recognize irAEs

Increased ability to manage immunotherapy and combination therapy toxicity

Be better able to implement patient-centric care designed to preserve or restore patient quality of life

Other (please explain)

Question Title

* 8. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

Question Title

* 9. After participating in today’s activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Identify both preventable and inescapable risk factors that drive mortality rates in advanced and recurrent EC	Identify both preventable and inescapable risk factors that drive mortality rates in advanced and recurrent EC Strongly agree	Identify both preventable and inescapable risk factors that drive mortality rates in advanced and recurrent EC Agree	Identify both preventable and inescapable risk factors that drive mortality rates in advanced and recurrent EC Neutral	Identify both preventable and inescapable risk factors that drive mortality rates in advanced and recurrent EC Disagree	Identify both preventable and inescapable risk factors that drive mortality rates in advanced and recurrent EC Strongly disagree
Select appropriate and individualized treatment approaches for each EC patient based on genomic subtypes and molecular markers	Select appropriate and individualized treatment approaches for each EC patient based on genomic subtypes and molecular markers Strongly agree	Select appropriate and individualized treatment approaches for each EC patient based on genomic subtypes and molecular markers Agree	Select appropriate and individualized treatment approaches for each EC patient based on genomic subtypes and molecular markers Neutral	Select appropriate and individualized treatment approaches for each EC patient based on genomic subtypes and molecular markers Disagree	Select appropriate and individualized treatment approaches for each EC patient based on genomic subtypes and molecular markers Strongly disagree
Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments	Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments Strongly agree	Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments Agree	Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments Neutral	Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments Disagree	Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments Strongly disagree
Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL	Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL Strongly agree	Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL Agree	Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL Neutral	Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL Disagree	Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL Strongly disagree

Question Title

* 10. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree

Question Title

* 11. This activity was free from commercial bias.

Yes

Question Title

* 12. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 13. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 14. What barriers do you see to making changes in your practice? Please select all that apply.

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other

Unlocking Epigenetic Secrets from the Womb: Therapeutic Options for Advanced and Recurrent Endometrial Cancer Evaluation (ID: i778-6)

Question Title

* 1. What is your degree?

Question Title

* 2. What is your specialty?

Question Title

* 3. Please select the option that best describes your practice:

Question Title

* 4. How many years have you been in practice?

Question Title

* 5. How many patients with EC do you treat each week?

Question Title

* 6. After participating in this activity, how confident are you in the management of patients with EC in your practice?

Question Title

* 7. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 8. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 9. After participating in today’s activity, I am now better able to:

Question Title

* 10. The content presented:

Question Title

* 11. This activity was free from commercial bias.

Question Title

* 12. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 13. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 14. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 15. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities: